Kerntke Otto McGlone Wealth Management Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-368
Closed -$217K 59
2022
Q1
$217K Hold
368
0.5% 33
2021
Q4
$245K Hold
368
0.3% 56
2021
Q3
$210K Buy
+368
New +$202K 0.63% 35
2021
Q1
Sell
-445
Closed -$207K 131
2020
Q4
$207K Buy
+445
New +$209K 0.12% 112
2020
Q1
Sell
-2,182
Closed -$709K 107
2019
Q4
$709K Buy
+2,182
New +$662K 0.6% 45

Other funds holding TMO

Kerntke Otto McGlone Wealth Management Group's TMO Position: Q2 2022 in Review

Kerntke Otto McGlone Wealth Management Group sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 368 shares — an estimated $217K sold.

Kerntke Otto McGlone Wealth Management Group first reported a position in TMO in Q4 2019 and held it in 5 quarters. The position peaked at $709K in Q4 2019. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Kerntke Otto McGlone Wealth Management Group reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
  • Kerntke Otto McGlone Wealth Management Group sold 368 Thermo Fisher Scientific shares in Q2 2022, an estimated $217K.
  • Kerntke Otto McGlone Wealth Management Group first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 5 quarters.
  • Kerntke Otto McGlone Wealth Management Group's Thermo Fisher Scientific position peaked at $709K in Q4 2019.
  • 2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Kerntke Otto McGlone Wealth Management Group's 13F filing for Q2 2022, filed 12 Aug 2022.